rs143119940

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 1P and 12B. PP3BP6_Very_StrongBS2

The NM_000170.3(GLDC):​c.2203G>T​(p.Val735Leu) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0058 in 1,610,402 control chromosomes in the GnomAD database, including 78 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0062 ( 20 hom., cov: 33)
Exomes 𝑓: 0.0058 ( 58 hom. )

Consequence

GLDC
NM_000170.3 missense, splice_region

Scores

5
10
4
Splicing: ADA: 0.9998
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 7.53
Variant links:
Genes affected
GLDC (HGNC:4313): (glycine decarboxylase) Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). The protein encoded by this gene is the P protein, which binds to glycine and enables the methylamine group from glycine to be transferred to the T protein. Defects in this gene are a cause of nonketotic hyperglycinemia (NKH).[provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: BayesDel_noAF, Cadd, dbscSNV1_ADA, dbscSNV1_RF, M_CAP, phyloP100way_vertebrate, REVEL [when BayesDel_addAF, FATHMM_MKL, MetaRNN, MutationAssessor, MutationTaster was below the threshold]
BP6
Variant 9-6554781-C-A is Benign according to our data. Variant chr9-6554781-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 367181.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-6554781-C-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GLDCNM_000170.3 linkuse as main transcriptc.2203G>T p.Val735Leu missense_variant, splice_region_variant 19/25 ENST00000321612.8 NP_000161.2 P23378

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GLDCENST00000321612.8 linkuse as main transcriptc.2203G>T p.Val735Leu missense_variant, splice_region_variant 19/251 NM_000170.3 ENSP00000370737.4 P23378

Frequencies

GnomAD3 genomes
AF:
0.00623
AC:
949
AN:
152250
Hom.:
20
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000868
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00647
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0412
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00532
Gnomad OTH
AF:
0.00574
GnomAD3 exomes
AF:
0.00642
AC:
1575
AN:
245208
Hom.:
26
AF XY:
0.00638
AC XY:
844
AN XY:
132286
show subpopulations
Gnomad AFR exome
AF:
0.00115
Gnomad AMR exome
AF:
0.00217
Gnomad ASJ exome
AF:
0.000101
Gnomad EAS exome
AF:
0.000110
Gnomad SAS exome
AF:
0.000170
Gnomad FIN exome
AF:
0.0387
Gnomad NFE exome
AF:
0.00560
Gnomad OTH exome
AF:
0.00635
GnomAD4 exome
AF:
0.00575
AC:
8390
AN:
1458034
Hom.:
58
Cov.:
31
AF XY:
0.00568
AC XY:
4120
AN XY:
725014
show subpopulations
Gnomad4 AFR exome
AF:
0.000599
Gnomad4 AMR exome
AF:
0.00297
Gnomad4 ASJ exome
AF:
0.000154
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.000187
Gnomad4 FIN exome
AF:
0.0332
Gnomad4 NFE exome
AF:
0.00555
Gnomad4 OTH exome
AF:
0.00473
GnomAD4 genome
AF:
0.00623
AC:
949
AN:
152368
Hom.:
20
Cov.:
33
AF XY:
0.00721
AC XY:
537
AN XY:
74506
show subpopulations
Gnomad4 AFR
AF:
0.000866
Gnomad4 AMR
AF:
0.00647
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.0412
Gnomad4 NFE
AF:
0.00532
Gnomad4 OTH
AF:
0.00568
Alfa
AF:
0.00455
Hom.:
3
Bravo
AF:
0.00398
TwinsUK
AF:
0.00431
AC:
16
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00291
AC:
25
ExAC
AF:
0.00545
AC:
662
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsSep 06, 2017- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2024GLDC: BS2 -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Glycine encephalopathy Benign:3
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Jan 08, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Benign
-0.0014
T
BayesDel_noAF
Pathogenic
0.23
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.68
D;.;.
Eigen
Uncertain
0.19
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;D;D
M_CAP
Pathogenic
0.35
D
MetaRNN
Benign
0.011
T;T;T
MetaSVM
Uncertain
0.63
D
MutationAssessor
Benign
1.6
L;.;.
PrimateAI
Uncertain
0.73
T
PROVEAN
Uncertain
-2.6
D;.;.
REVEL
Pathogenic
0.85
Sift
Uncertain
0.0070
D;.;.
Sift4G
Uncertain
0.0090
D;.;.
Polyphen
0.21
B;.;.
Vest4
0.92
MutPred
0.67
Gain of sheet (P = 0.1945);.;.;
MVP
0.98
MPC
0.17
ClinPred
0.026
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.75
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.97
SpliceAI score (max)
0.42
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.42
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143119940; hg19: chr9-6554781; COSMIC: COSV100394782; COSMIC: COSV100394782; API